| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | MYO Myomo, Inc. | Henry David A72 | Chief Financial Officer | Buy | 9,000 | $0.55 | $4,959.90 | +11.6% | +11.6% | +477.2% | |
| Nov 22, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 121 | $20.20 | $2,444.20 | -0.3% | -1.4% | -36.9% | |
| Nov 22, 2022 | UFPT Ufp Technologies Inc | Oberdorf Thomas | Director | Sell | 15,333 | $116.97 | $1,793,473.61 | -13.6% | -0.4% | +46.0% | |
| Nov 22, 2022 | RMD Resmed Inc | Leong Justin | President, Asia Latin America | Sell | 3,777 | $229.50 | $866,819.61 | -5.9% | -6.3% | -33.5% | |
| Nov 22, 2022 | ECOR Electrocore, Inc. | Errico Joseph P59 | Director | Buy | 75,000 | $0.33 | $24,967.50 | +3.5% | -21.5% | +23.0% | |
| Nov 22, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 1,000 | $2.50 | $2,500.00 | +0.1% | - | - | |
| Nov 22, 2022 | OM Outset Medical, Inc. | Hinrichs James F.45 | Director | Buy | 7,500 | $17.84 | $133,800.00 | +18.7% | +32.9% | -71.5% | |
| Nov 22, 2022 | NPCE Neuropace Inc | Accelmed Partners II L.P.52 | 10% Owner | Buy | 390,291 | $1.50 | $585,046.21 | +4.6% | +256.0% | +479.3% | |
| Nov 22, 2022 | MLSS Milestone Scientific Inc. | Goldman Neal I79 | Director | Buy | 54,905 | $0.63 | $34,589.08 | +2.1% | +2.1% | +26.0% | |
| Nov 22, 2022 | TMCI Treace Medical Concepts, Inc. | Timbie Thomas E69 | Director | Sell | 50,000 | $22.58 | $1,128,914.82 | -0.9% | -1.6% | -61.2% | |
| Nov 21, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 22,886 | $3.25 | $74,471.04 | -1.8% | -18.6% | -89.3% | |
| Nov 21, 2022 | TMCI Treace Medical Concepts, Inc. | Berutti Aaron | Sr. VP, Sales | Buy | 1,825 | $21.86 | $39,894.32 | +15.3% | +0.6% | -61.0% | |
| Nov 21, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 6,018 | $3.28 | $19,751.08 | -1.8% | -18.6% | -89.3% | |
| Nov 21, 2022 | PETV Petvivo Holdings, Inc. | Rudelius Robert James | Director | Buy | 860 | $2.65 | $2,279.00 | +0.4% | - | - | |
| Nov 21, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 6,069 | $3.28 | $19,918.46 | -1.9% | -18.6% | -89.3% | |
| Nov 21, 2022 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 9,877 | $117.72 | $1,162,707.91 | -2.8% | -0.1% | +47.3% | |
| Nov 21, 2022 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Buy | 15,000 | $21.83 | $327,405.00 | +0.3% | +0.6% | -61.0% | |
| Nov 21, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 1,000 | $2.55 | $2,550.00 | +0.1% | - | - | |
| Nov 21, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 18,041 | $3.29 | $59,264.69 | -1.8% | -18.6% | -89.3% | |
| Nov 21, 2022 | RCEL Avita Medical, Inc. | Perry Michael S55 | Director | Sell | 150,000 | $7.18 | $1,077,000.00 | -39.5% | +27.0% | +41.6% | |
| Nov 21, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 5,787 | $1.26 | $7,312.45 | -0.8% | +24.2% | +12.1% | |
| Nov 21, 2022 | VERO Venus Concept Inc. | Portaro Ross | President Global Sales | Buy | 60,000 | $0.22 | $13,200.00 | +100.0% | +20.7% | -44.3% | |
| Nov 21, 2022 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 2,400 | $112.62 | $270,288.00 | -3.4% | +1.2% | -3.3% | |
| Nov 21, 2022 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $14.66 | $293,200.00 | -0.2% | -25.7% | -58.1% | |
| Nov 21, 2022 | INFU Infusystem Holdings, Inc | Sansone Christopher R. | Director | Sell | 80,838 | $8.13 | $656,863.22 | -19.5% | +13.9% | +12.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.